enVVeno Medical Corp (NVNO) — Institutional Holders, Q2 2026
17 institutional investment managers reported a NVNO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $953.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NVNO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Mirae Asset Global Investments , Ltd.New · +539 sh+$5.8K
- BARCLAYS PLCNew · +2 sh+$21.00
Biggest sellers
- GEODE CAPITAL MANAGEMENTSold out · -10,455 sh-$112.0K
- BlackRockTrimmed · -1,426 sh-$15.3K
- UBS Group AGTrimmed · -242 sh-$2.6K
- Tower Research Capital (TRC)Trimmed · -211 sh-$2.3K
- Westside Investment ManagementTrimmed · -64 sh-$685.00
NVNO 13F holders ranked 1–17 of 17
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | KINGDON CAPITAL MANAGEMENT, L.L.C.#1 · 36,166 sh | 36,166 | $387.3K | 0.04% | 0.0% |
| 2 | CM Management#2 · 35,714 sh | 35,714 | $382.5K | 0.24% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 6,287 sh | 6,287 | $67.4K | 0.00% | 0.0% |
| 4 | JPMORGAN CHASE#4 · 5,208 sh | 5,208 | $59.1K | 0.00% | 0.0% |
| 5 | VANGUARD FIDUCIARY#5 · 2,184 sh | 2,184 | $23.4K | 0.00% | 0.0% |
| 6 | Westside Investment Management#6 · 1,525 sh | 1,525 | $16.3K | <0.01% | -4.0% |
| 7 | Mirae Asset Global Investments , Ltd.#7 · 539 sh | 539 | $5.8K | 0.00% | New |
| 8 | BlackRock#8 · 414 sh | 414 | $4.4K | 0.00% | -77.5% |
| 9 | Tower Research Capital (TRC)#9 · 331 sh | 331 | $3.5K | <0.01% | -38.9% |
| 10 | WELLS FARGO & COMPANY#10 · 114 sh | 114 | $1.2K | 0.00% | 0.0% |
| 11 | Allied Private Wealth#11 · 88 sh | 88 | $978.00 | <0.01% | — |
| 12 | Vanguard Global Advisers#12 · 77 sh | 77 | $825.00 | 0.00% | 0.0% |
| 13 | MORGAN STANLEY#13 · 59 sh | 59 | $632.00 | 0.00% | -22.4% |
| 14 | OSAIC#14 · 7 sh | 7 | $74.00 | 0.00% | 0.0% |
| 15 | BARCLAYS PLC#15 · 2 sh | 2 | $21.00 | 0.00% | New |
| 16 | GROUP ONE TRADING, L.P.#16 · 2 sh | 2 | $21.00 | 0.00% | 0.0% |
| 17 | UBS Group AG#17 · 1 sh | 1 | $11.00 | 0.00% | -99.6% |
Funds that sold out of NVNO in Q2 2026 (3)
Held NVNO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| GEODE CAPITAL MANAGEMENT10,455 sh | 10,455 | $105.9K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT2 sh | 2 | $20.00 |
| CITIGROUP1 sh | 1 | $10.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.